Related Experiment Videos
[Chronic inflammatory bowel diseases competence network ].
U R Fölsch1, J Grebe, S Schreiber
11. Medizinische Universitätsklinik, Klinikum der Christian-Albrechts-Universität Kiel. urfoelsch@1med.uni-kiel.de
Der Internist
|March 5, 2004
Summary
Inflammatory bowel diseases (IBD) are chronic conditions affecting young adults, with genetic and environmental factors contributing to their development. A specialized network enhances IBD research and patient care through integrated data and improved clinical studies.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Context:
- Inflammatory bowel diseases (IBD) are chronic conditions impacting young adults (20-30 years), affecting quality of life and socioeconomic factors.
- IBD etiology involves complex interactions between genetic predisposition and environmental triggers, particularly in Crohn's disease.
- Current understanding of IBD pathogenesis is evolving, driving the development of novel therapeutic strategies.
Purpose:
- To highlight the role of the competence network IBD in advancing scientific and clinical research for inflammatory bowel diseases.
- To emphasize the network's structure, integrating university and non-university hospitals, labs, patient organizations (DCCV), and general practitioners.
- To facilitate standardized patient data integration, guideline development, and quality management systems for IBD.
Summary:
- The competence network IBD facilitates large-scale clinical studies by uniting diverse healthcare entities and patient groups.
- It enables a dual perspective—scientific and clinical—on IBD, crucial for understanding disease patterns and patient experiences.
- The network's collaborative approach supports the development of evidence-based guidelines and quality improvement initiatives in IBD care.
Impact:
- Improved understanding of IBD triggers, including genetic factors and environmental influences.
- Accelerated development and testing of new therapies for inflammatory bowel diseases through collaborative clinical trials.
- Enhanced patient care and outcomes via standardized data, improved guidelines, and robust quality management within the IBD network.